BIOVENTUS INC. Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits
BIOVENTUS INC. (BVS) had Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits of $417.00 thousand as of 2025-12-31, per its 10-K filed 2026-03-05.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Tax Deferred Expense
us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits · last filed 2026-03-05
- 2025-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits $417.00K.
- 2024-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits $283.00K.
- 2023-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits $947.00K.
- 2022-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits $681.00K.
| Period end | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits |
|---|---|
| 2025-12-31 | $417.00K 10-K · filed 2026-03-05 |
| 2024-12-31 | $283.00K 10-K · filed 2026-03-05 |
| 2023-12-31 | $947.00K 10-K · filed 2025-03-11 |
| 2022-12-31 | $681.00K 10-K · filed 2024-03-12 |